MDLZ
32
8
PEP
38
12
HPE
35
2
AIZ
42
2
ZION
63
2
TDC
49
-5
TGNA
39
4
WBA
35
-3
DHI
29
2
AA
48
-3
SJM
11
5
AMG
50
-2
NAVI
32
8
ADSK
54
4
SWKS
42
2
GT
21
-2
ED
45
2
GLW
53
-2
PNR
59
2
LNC
48
5
MDLZ
32
8
PEP
38
12
HPE
35
2
AIZ
42
2
ZION
63
2
TDC
49
-5
TGNA
39
4
WBA
35
-3
DHI
29
2
AA
48
-3
SJM
11
5
AMG
50
-2
NAVI
32
8
ADSK
54
4
SWKS
42
2
GT
21
-2
ED
45
2
GLW
53
-2
PNR
59
2
LNC
48
5
Financhill
Back

Logitech International SA Vs. Blueprint Medicines Industry Stock Comparison

Sell
38

LOGI
Logitech International SA

Last Price:
$83.65
Seasonality Move:
-2.52%
Buy
52

BPMC
Blueprint Medicines

Last Price:
$128.14
Seasonality Move:
10.35%
Sell
38
Logitech International SA (LOGI) is a Sell

Is Logitech International SA a Buy, Sell or Hold?

  • The current Logitech International SA [LOGI] share price is $83.64. The Score for LOGI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • LOGI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Blueprint Medicines (BPMC) is a Buy

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $128.20. The Score for BPMC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

LOGI Stock Price Chart

What is Logitech International SA's stock price today?

  • The Logitech International SA share price today is $83.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LOGI is experiencing selling pressure, which indicates risk of future bearish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $128.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.

LOGI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.67 Buy
Relative Strength Index (14 RSI): 47.23 Sell
Chaikin Money Flow: -381781 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (83.86 - 86.96) Sell
Bollinger Bands (100): (77.43 - 97.19) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.7 Buy
Relative Strength Index (14 RSI): 75.62 Buy
Chaikin Money Flow: 1502050 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (102.43 - 129.61) Buy
Bollinger Bands (100): (85.02 - 113.84) Buy

LOGI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.97 Sell
20-day SMA: 85.06 Sell
50-day SMA: 81.08 Buy
200-day SMA: 85.83 Sell
8-day EMA: 85.18 Sell
20-day EMA: 84.89 Sell
50-day EMA: 84.09 Sell
200-day EMA: 85.59 Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.11 Buy
20-day SMA: 119.69 Buy
50-day SMA: 103.32 Buy
200-day SMA: 95.92 Buy
8-day EMA: 127.3 Buy
20-day EMA: 120.82 Buy
50-day EMA: 109.36 Buy
200-day EMA: 98.18 Buy

Logitech International SA Earnings Growth & LOGI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.86 per share, and a decrease next year of $0.29 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

Logitech International SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):